Literature DB >> 21325954

5-HT2A receptor gene polymorphisms and irritable bowel syndrome.

Theofano Markoutsaki1, Theodoros Karantanos, Maria Gazouli, Nicholas P Anagnou, Dimitrios G Karamanolis.   

Abstract

GOALS: The aim of the study was to investigate the potential association between single nucleotide polymorphisms of the 5-HT2A receptor gene and susceptibility to irritable bowel syndrome (IBS) in the Greek population.
BACKGROUND: Serotonin [5-hydroxytryptamine (5-HT)] is the main mediator involved in the pathophysiology of IBS. Thus, genes implicated in 5-HT metabolism are good candidates for susceptibility to IBS. Two single nucleotide polymorphisms -1438 (G/A) and 102 (C/T) in the 5-HT2A receptor gene have been associated with the pathophysiology of IBS. STUDY: One hundred twenty-four patients with IBS diagnosed according to the Rome III criteria and 238 healthy individuals were included in the study. The -1438 (G/A) and 102 (C/T) in the 5-HT2A receptor gene polymorphisms have been studied using the polymerase chain reaction based restriction fragment length polymorphism method.
RESULTS: A genotype association was found between A allele and AA genotype of the -1438 (G/A) polymorphism and IBS (P=0.0037 and P=0.0064, respectively). Concerning the 102 (C/T) polymorphism, no significant association was found.
CONCLUSIONS: This study suggests that the carriers of A allele of the -1438 (G/A) polymorphism of the 5-HT2A receptor gene have a high risk of IBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325954     DOI: 10.1097/MCG.0b013e318205e13b

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  New paradigm for studying genetic contributions to irritable bowel syndrome.

Authors:  Miranda A L van Tilburg; William E Whitehead
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

Review 4.  Genetic epidemiology of irritable bowel syndrome.

Authors:  Jasbir Makker; Sridhar Chilimuri; Jonathan N Bella
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

5.  Serotonin-Related Gene Variants in Patients with Irritable Bowel Syndrome and Depressive or Anxiety Disorders.

Authors:  Magdalena Grzesiak; Jan Aleksander Beszłej; Ewa Waszczuk; Marcin Szechiński; Monika Szewczuk-Bogusławska; Dorota Frydecka; Tadeusz Dobosz; Anna Jonkisz; Arleta Lebioda; Małgorzata Małodobra; Agata Mulak
Journal:  Gastroenterol Res Pract       Date:  2017-08-16       Impact factor: 2.260

Review 6.  Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders.

Authors:  Yi Liu; Jingping Zhao; Xiaoduo Fan; Wenbin Guo
Journal:  Front Psychiatry       Date:  2019-05-21       Impact factor: 4.157

Review 7.  Ethnic differences in genetic polymorphism associated with irritable bowel syndrome.

Authors:  Qi-Yun Xiao; Xiu-Cai Fang; Xiao-Qing Li; Gui-Jun Fei
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

Review 8.  Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

9.  Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo.

Authors:  Felix Nau; Bangning Yu; David Martin; Charles D Nichols
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

Review 10.  The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies.

Authors:  Zhi-Feng Zhang; Zhi-Jun Duan; Li-Xia Wang; Dong Yang; Gang Zhao; Lin Zhang
Journal:  BMC Gastroenterol       Date:  2014-02-10       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.